New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
GeneDx Holdings Corp.
WGS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Medical - Healthcare Information Services

Next Earning date - 18 Feb 2025

2B

Medical - Healthcare Information Services

Next Earning date - 18 Feb 2025

76.35USD

Shape-1.65 ( -2.12%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

57%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

23%

Quote Panel

Shape
Updated February 17, 2025
1W 12.61 % 1M 2.68 % 3M 7.38 % 1Y 1357.06 %

Key Metrics

Shape
  • Market Cap

    2.10B


  • Shares Outstanding

    27.47M


  • Share in Float

    22.05M


  • Dividende

    0


  • Earning Date

    18 Feb 2025


  • Price Target

    76.35


  • Average Volume

    805143


  • Beta

    2.078


  • Range

    4.612-98.87


  • Industry

    Medical - Healthcare Information Services


  • Website

    http://www.genedx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

WGS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$339M

Shape341%

2025-Revenue

$0.55

Shape277%

2025-EPS

$257M

Shape-13767%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Not converted

2024-08-27

Now: Equal-Weight

Craig-Hallum

initialise

Previous: Not converted

2024-07-10

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.25
vs -0.17

Q1.23

arrow
arrow

N/A

-2.82
vs -0.31

Q2.23

arrow
arrow

N/A

-1.65
vs -0.25

Q3.23

arrow
arrow

N/A

-0.82
vs -0.20

Q4.23

arrow
arrow

N/A

-0.59
vs -0.25

Q1.24

arrow
arrow

N/A

-0.33
vs -2.82

Q2.24

arrow
arrow

N/A

-0.11
vs -1.65

Q3.24

arrow
arrow

+105%

0.04
vs -0.82

Q4.24

arrow
arrow

+128%

0.16
vs -0.59

Q1.25

arrow
arrow

+119%

0.06
vs -0.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+6%

61.4M  vs 57.8M

Q1.23

arrow
arrow

-20%

43.1M  vs 53.9M

Q2.23

arrow
arrow

+35%

48.7M  vs 36.2M

Q3.23

arrow
arrow

-36%

53.3M  vs 83.2M

Q4.23

arrow
arrow

-6%

57.4M  vs 61.4M

Q1.24

arrow
arrow

+45%

62.4M  vs 43.1M

Q2.24

arrow
arrow

+45%

70.5M  vs 48.7M

Q3.24

arrow
arrow

+44%

76.9M  vs 53.3M

Q4.24

arrow
arrow

+43%

82.2M  vs 57.4M

Q1.25

arrow
arrow

+25%

78M  vs 62.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-122%

-1.22
vs -0.14

Q1.23

arrow
arrow

-19%

-0.19
vs -1.22

Q2.23

arrow
arrow

-16%

-0.16
vs -0.19

Q3.23

arrow
arrow

-17%

-0.17
vs -0.16

Q4.23

arrow
arrow

-11%

-0.11
vs -0.17

Q1.24

arrow
arrow

-10%

-0.10
vs -0.11

Q2.24

arrow
arrow

-15%

-0.15
vs -0.10

Q3.24

arrow
arrow

-4%

-0.04
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

2

2
vs NA

NA

Q2.23

arrow
arrow

62

62
vs 2

3000%

Q3.23

arrow
arrow

58

58
vs 62

-6%

Q4.23

arrow
arrow

50

50
vs 58

-14%

Q1.24

arrow
arrow

61

61
vs 50

22%

Q2.24

arrow
arrow

92

92
vs 61

51%

Q3.24

arrow
arrow

145

145
vs 92

58%

Q4.24

arrow
arrow

198

198
vs 145

37%

Earnings Growth

Latest News